agilon health, inc. (AGL)
NYSE: AGL · Real-Time Price · USD
96.78
+1.27 (1.33%)
At close: Aug 10, 2026, 4:00 PM EDT
98.01
+1.23 (1.27%)
Pre-market: Aug 11, 2026, 7:16 AM EDT

agilon health Stock Forecast

Stock Price Forecast

According to 16 analysts polled by S&P Global, agilon health stock has a consensus rating of "Hold" and an average price target of $110.92. The average 1-year stock price forecast is 14.61% higher than the current stock price, while the lowest is $31 (-67.97%) and the highest is $146 (+50.86%).

Price Target: $110.92 (+14.61%)
Analyst Consensus: Hold

Price Target

Chart
TargetLowAverageMedianHigh
Price$31$110.92$115$146
Change-67.97%+14.61%+18.83%+50.86%

Analyst Ratings

The average analyst rating for agilon health stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Jun '26Jul '26Aug '26
Strong Buy224444
Buy000000
Hold131311111010
Sell222221
Strong Sell000011
Total171717171716

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Citi
Citi
Hold
Upgrades
$105$115
HoldUpgrades$105$115+18.83%Aug 10, 2026
TD Cowen
TD Cowen
Hold
Maintains
$55$95
HoldMaintains$55$95-1.84%Aug 7, 2026
Bernstein
Bernstein
Hold
Maintains
$86
HoldMaintains$86-11.14%Aug 6, 2026
Robert W. Baird
Robert W. Baird
Hold
Maintains
$35$116
HoldMaintains$35$116+19.86%Aug 6, 2026
Benchmark Co.
Benchmark Co.
Buy
Maintains
$95$140
BuyMaintains$95$140+44.66%Aug 6, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
5.81B
from 5.93B
Decreased by -2.00%
Revenue Next Year
6.20B
from 5.81B
Increased by 6.70%
EPS This Year
-0.66
from -21.86
EPS Next Year
1.16
from -0.66
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
1.52B2.39B4.32B6.06B5.93B5.81B
Revenue Growth
24.88%56.97%80.74%40.41%-2.11%-2.00%
Gross Profit
65.74M111.36M69.67M4.84M-160.02M221.90M
Gross Margin
4.32%4.66%1.61%0.08%-2.70%3.82%
Operating Income
-366.84M-102.91M-231.95M-283.96M-421.08M-81.55M
Net Income
-406.49M-106.55M-262.60M-260.15M-391.35M-37.44M
EPS
-----21.86-0.66
Free Cash Flow
4.09M-131.38M-64.40M-35.88M-81.23M-87.45M
No. Analysts
-----13
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High5.9B
Avg5.8B
Low5.7B

Revenue Growth

Revenue Growth202620272028
High
-1.3%
Avg
-2.0%
Low
-3.7%

EPS Forecast

EPS202620272028
High3.08
Avg-0.66
Low-4.81

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-